Janumet XR
Sponsors
ADIUM
Conditions
BioequivalanceBioequivalence
Unknown Phase
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.
CompletedNCT07763912
Start: 2025-11-24End: 2025-12-05Updated: 2026-08-14
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.
CompletedNCT07763899
Start: 2025-11-19End: 2025-11-30Updated: 2026-08-14
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study.
CompletedNCT07763964
Start: 2025-12-08End: 2025-12-19Updated: 2026-08-14
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.
CompletedNCT07763951
Start: 2025-12-03End: 2025-12-14Updated: 2026-08-14